# Arbutus Biopharma Corp: Form 8-K, filed Nov 13, 2025

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2025-11-13
- Accepted by EDGAR: Nov 13, 2025, 07:31 ET
- Period: 2025-11-13
- Accession: 0001171843-25-007256
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184325007256/f8k_111325.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184325007256/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184325007256/f8k_111325.htm

Filed Nov 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-007256. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.